Impact Biomedical (IBO) Selling, General & Administrative (2022 - 2026)
Impact Biomedical (IBO) reported Selling, General & Administrative of $167,000 for Q2 2026, down 32.1% from $246,000 a year earlier and down 89.7% from the prior quarter.
Powered by 
Analysis
Impact Biomedical (IBO) Selling, General & Administrative (2022 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Impact Biomedical's Selling, General & Administrative came in at $1.61 million, up 74.5% year-over-year; for FY2025, it was $312,000, down 56.5% from FY2024.
- Selling, General & Administrative has a three-year compound annual growth rate of -1.4% (FY2022 to FY2025).
- By year, Selling, General & Administrative came in at $718,000 in FY2024 (+127.9%), $315,000 in FY2023 (-3.1%) and $325,000 in FY2022.
- Five-year quarterly Selling, General & Administrative spans a low of -$443,000 in Q4 2025 and a high of $1.62 million in Q1 2026.
- Year over year, Selling, General & Administrative gained in six of the last seven quarters, with growth averaging 129.7%.
- The high point for year-over-year Selling, General & Administrative in five years was Q1 2026 (growth of 553.2%); the low point was Q2 2026 (a decline of 32.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.62 million (Q1 2026), -$443,000 (Q4 2025) and $261,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Impact Biomedical | 573.61 Mn | 576.81 Mn | 2,000.00 | 167,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 167,000.00 |
| Mar 31, 2026 | 1.62 Mn |
| Dec 31, 2025 | -443,000.00 |
| Sep 30, 2025 | 261,000.00 |
| Jun 30, 2025 | 246,000.00 |
| Mar 31, 2025 | 248,000.00 |
| Dec 31, 2024 | 294,000.00 |
| Sep 30, 2024 | 132,000.00 |
| Jun 30, 2024 | 145,000.00 |
| Mar 31, 2024 | 148,000.00 |
| Dec 31, 2023 | 133,000.00 |
| Sep 30, 2023 | 101,000.00 |
| Jun 30, 2023 | 41,000.00 |
| Mar 31, 2023 | 40,000.00 |
| Dec 31, 2022 | 39,000.00 |
| Sep 30, 2022 | 90,000.00 |
| Jun 30, 2022 | 58,000.00 |
API Access
Impact Biomedical Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();